Specialized Product Focus Nordic Pharma's emphasis on developing and commercializing niche hospital and orphan drugs positions it for growth within specialized medical fields such as rheumatology, women's health, and critical care, offering targeted sales opportunities to healthcare providers serving these patient populations.

European and North American Expansion With a strong presence in Europe and recent entry into the US market through product launches like Lacrifill and Maxitrol, there is significant potential to expand sales channels by engaging ophthalmology and hospital healthcare providers in these key regions.

Innovative Ophthalmology Portfolio The launch of novel ophthalmic treatments such as Lacrifill Canalicular Gel and Maxitrol authorized generics creates opportunities to connect with ophthalmologists and eye care clinics seeking advanced dry eye therapies and infection treatments.

Acquisition and Product Pipeline Growth Recent acquisition of Visant Medical and ongoing product development activities indicate a growing product pipeline, providing avenues to position new therapeutic solutions to hospitals and specialists focused on unmet medical needs.

Strategic Industry Partnerships Partnerships like the collaboration with Harrow for eye care products highlight opportunities to collaborate with industry leaders and expand distribution networks in North America, enhancing market penetration and sales opportunities.